Skip to content

New Jersey 222

A 3242

Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.

Open original source Back to bills

Official record

Measure details

Jurisdiction: New Jersey
Session: 222
Chamber: lower
Classification: bill
Subjects: Not supplied
Introduced / first action: 2026-01-13 05:00:00

Sponsors

Hutchison, Dan (primary), primary
Donlon, Margie, M.D. (primary), primary
Simmons, Heather (primary), primary
Miller, Cody D., cosponsor
Bagolie, Rosaura, cosponsor
Reynolds-Jackson, Verlina, cosponsor
Sampson, William B., IV, cosponsor
Venezia, Michael, cosponsor

Source-supplied history

Actions

2026-10-29 04:00:00
Passed by the Assembly (72-0-5)
passage
2026-09-17 04:00:00
Reported out of Assembly Committee, 2nd Reading
committee-passage, reading-2
2026-02-12 05:00:00
Reported out of Asm. Comm. with Amendments, and Referred to Assembly Appropriations Committee
referral-committee
2026-01-13 05:00:00
Introduced, Referred to Assembly Financial Institutions and Insurance Committee
introduction, referral-committee

Documents and versions

Official links

Recorded votes

Roll calls

No recorded vote is supplied for this bill.

When supplied by the API

Related measures

S 1102: companion

Traceable provenance

Source records

Provider updated: 2026-10-30 12:05:03. Locally fetched: 2026-10-31 03:12:08.